Human Growth Hormone Drugs: Market Research Report

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 [email protected] http://marketpublishers.com

Phone: +44 20 8123 2220 http://marketpublishers.com

Human Growth Hormone Drugs: Market Research Report Date: Pages: Price: ID:

January 6, 2014 127 US$ 4,950.00 HA07779AC1EEN

This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million by the following Brands: Humatrope, Norditropin, Genotropin, Nutropin, Saizen, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 30 companies including many key and niche players such as Eli Lilly and Company Ferring Holding SA Genentech, Inc. GeneScience Pharmaceuticals Co., Ltd. Merck Serono SA

Table of Content I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations Disclaimers Data Interpretation & Reporting Level Quantitative Techniques & Analytics Product Definitions and Scope of Study II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW Market Primer Evolution of Recombinant Human Growth Hormones (hGH) Rapid Adoption of hGH Replacement Therapy Patent Expiry Paves Way for the Emergence of Biosimilar List of Select Approved Prescription Daily-dose hGH Products by Indication Strong Innovation Drive in hGH Industry Outlook US - The Single-Largest Market for HGH Drugs Asia-Pacific – High Potential Market for hGH Drugs Key Growth Drivers High Prevalence of Growth Hormone Deficiency Disorders Innovations Hold the Key to Market Growth Manufacturers Bet on Novel Drug Delivery Technologies New Indications for hGH Replacement Therapy Major Growth Restraining Factors

Human Growth Hormone Drugs: Market Research Report

2

Phone: +44 20 8123 2220 http://marketpublishers.com

Complex Delivery System High Cost of hGH Treatment Difficulty in Securing Reimbursement Introduction of Biosimilars Erodes Revenue Growth Limited Pharmacological Differences Exist Among Current Agents 2. MARKET TRENDS & ISSUES Adult Growth Hormone Deficient Market Remains Underpenetrated

Table 1. Worldwide Recombinant Human Growth Hormone Market by End-use Indication (2013): Percentage Breakdown of Sales Revenues for Adult GHD, Turner Syndrome & Idiopathic Short Stature; Pediatric GHD; and Other Rare Conditions (includes corresponding Graph/Chart) Long-Acting hGH Drugs – a Potential Game Changer Select Long-Acting hGH Products in Pipeline by Development Stage Biosimilars Create Little Impact, Further Validation to Expand Indications and Growth

Table 2. Worldwide Biosimilar Demand by Product Category (2013): Percentage Breakdown of Value Sales for Epoetina, Granulocyte Colony-Stimulating Factors (G-CSFs), Interferons, Insulins, Low Molecular Weight Heparins (LMWH), Recombinant Human Growth Hormones (rhGHs), and Others (includes corresponding Graph/Chart) Biobetters Restrict Biosimilar Presence in Prescription hGH Market Phase IV Studies Necessitated for First Biosimilars Dose Titration – A Key to Achieve Enhanced Tolerability Needle-less Drug Delivery Systems to Wipe Out of Syringes

Table 3. Worldwide Pediatric rhGH Market by Geographic Region (2013): Percentage Breakdown of Sales Revenues for Europe, Japan, The United States, and Rest of World (includes corresponding Graph/Chart) Drug Delivery Device Options for Marketed hGH Products Risk of Cancer Necessitates Judicious Use of hGH in Children Growth Concerns about Prolonged Usage of Growth Hormones Growing Non-Prescription/Off-Label Usage – A Potential Health Hazard Oral hGH Secretagogues - An Alternative to Controversial hGH Injections in Professional Sports 3. COMPETITION MNC Manufacturers Dominate hGH Market, New Entrants to Intensify Competition

Table 4. Worldwide Human Growth Hormone Drugs Market by Leading Players (2014): Percentage Market Share Breakdown of Sales Revenues for Eli Lilly, Novo Nordisk, Merck Serono, Pfizer, Roche/Genentech, and Others (includes corresponding Graph/Chart) Norditropin Genotropin Humatrope Saizen Omnitrope – the Somatropin Biosimilar Somatropin Biopartners

Human Growth Hormone Drugs: Market Research Report

3

Phone: +44 20 8123 2220 http://marketpublishers.com

Review of Select hGH Products in Pipeline OPKO Biologics/ Prolor Biotech’s hGH-CTP Versartis VRS-317 Ambrx ARX201 HanAll’s Vitatropin 4. HUMAN GROWTH HORMONE: AN OVERVIEW Key Factors Controlling Natural hGH Secretion Structure of hGH Functions Performed by hGH in the Human Body Benefits of Adequate hGH Effects of Human Growth Hormone Imbalances Hypopituitarism Evolution of Growth Hormone Replacement Therapy Indications for Exogenous hGH Administration Growth Hormone Deficiency (GHD) Symptoms of Adult Growth Hormone Deficiency Idiopathic Short Stature Noonan Syndrome Prader-Willi Syndrome Turner Syndrome Short Stature Homeobox Gene Small for Gestational Age Chronic Renal Insufficiency Short Bowel Syndrome Other Medical Conditions Off-label Applications Contraindications for Somatropin Therapy Safety Review of hGH Therapy Reported Adverse Effects of Inaccurate rhGH Dosages Risks Involved with Pediatric/Adolescent hGH Replacement Therapy Risks Involved with Adult hGH Replacement Therapy 5. RECENT INDUSTRY ACTIVITY Pfizer Announces Positive Outcome in Phase 3B for Genotropin for SGA in Infants Hanmi Science Applies for Taiwan Patent for Liquid Long-Acting hGH Conjugate OPKO Health Acquires PROLOR Biotech, Renames as OPKO Biologics Somatropin Biopartners Awarded Approval by EMA Sandoz Unveils SurePal Injection Pen for Administering Omnitrope hGH Versartis Secures USFDA Orphan Drug Designation for VRS-317 hGH Ascendis Pharma Applies for Israel Patent for hGH Prodrug Conjugates Anke Biotech Files Application for New Indications of pegylation rhGH with China FDA Serono Lab Receives Cyprus Patent for Use of hGH for Mobilizing Pluripotent Hematopoietic Cells Generium Aozt Awarded Russian Patent for Commercial Production Process of hGH Novo Nordisk Reports Phase I Clinical Trial Data for NN 8640 rhGH Genentech’s Canadian and European Patents for Aqueous hGH Formulation Expire Hanmi Commences Phase II of Clinical Trials for LAPS-hGH in Romania PROLOR Initiates Phase III of Clinical Trials for hGH-CTP in US, Europe, Israel 6. FOCUS ON SELECT GLOBAL PLAYERS Eli Lilly and Company (US) Ferring Holding SA (Switzerland)

Human Growth Hormone Drugs: Market Research Report

4

Phone: +44 20 8123 2220 http://marketpublishers.com

Genentech, Inc. (US) GeneScience Pharmaceuticals Co. , Ltd. (China) Merck Serono SA (Switzerland) Novo Nordisk A/S (Denmark) Pfizer, Inc. (US) Sandoz International GmbH (Germany) Teva Pharmaceutical Industries Limited (Israel) 7. GLOBAL MARKET PERSPECTIVE

Table 5. World Recent Past, Current and Future Analysis for Human Growth Hormone Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 6. World Historic Analysis for Human Growth Hormone Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) Table 7. World 15-Year Perspective for Human Growth Hormone Drugs by Geographic Region Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2006, 2014, and 2020 (includes corresponding Graph/Chart) Table 8. World Recent Past, Current and Future Analysis for Human Growth Hormone Drugs by Brands Norditropin, Genotropin, Humatrope, Nutropin, Saizen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 9. World Historic Analysis for Human Growth Hormone Drugs by Brands - Norditropin, Genotropin, Humatrope, Nutropin, Saizen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) Table 10. World 15-Year Perspective for Human Growth Hormone Drugs by Brands - Percentage Breakdown of Dollar Sales for Norditropin, Genotropin, Humatrope, Nutropin, Saizen, and Others Markets for Years 2006, 2014, and 2020 (includes corresponding Graph/Chart) III. MARKET 1. THE UNITED STATES A. Market Analysis Current & Future Analysis US hGH Market – A Peek into GHD Prevalence and Cost of Treatment FDA Approvals Clear Way for Treating More Children Major hGH Drugs Available in the US, and FDA Approved Indications

Table 11. The US Human Growth Hormone Drugs Market by Leading Players (2013): Percentage Market Share Breakdown of Sales Revenues for Eli Lilly, Merck Serono, Novo Nordisk, Pfizer, Roche/Genentech, Sandoz, Teva Pharmaceutical (includes corresponding Graph/Chart) FDA Approval of First Biosimilars Omnitrope Versus Genotropin – A US Perspective FDA Issues First Draft of Guidelines for Biosimilar and Interchangeable Biologicals US FDA Promotes rhGH Development through Orphan Drug Designation

Human Growth Hormone Drugs: Market Research Report

5

Phone: +44 20 8123 2220 http://marketpublishers.com

FDA Regulations Governing hGH Products in the OTC Drugs Market Alarming Increase in Sales of hGH Drugs for Anti-Ageing Therapy Strategic Corporate Developments Select Key Players B. Market Analytics

Table 12. The US Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 13. The US Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 2. CANADA Market Analysis

Table 14. Canadian Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 15. Canadian Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 3. JAPAN A. Market Analysis Current & Future Analysis Japanese Biosimilar Regulatory Guidelines Sandoz’ Omnitrope – the First Biosimilar hGH Launched in Japan B. Market Analytics

Table 16. Japanese Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 17. Japanese Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 4. EUROPE A. Market Analysis Current & Future Analysis European hGH Market Focuses on Product Differentiation to Revitalize Sales Regulations Pertaining to Biosimilars in the EU

Table 18. Adoption Rates for hGH Biosimilar in Major Western Europe Markets: 2013 (includes corresponding Graph/Chart) Uneven Adoption of Biosimilar hGH across EU Members

Human Growth Hormone Drugs: Market Research Report

6

Phone: +44 20 8123 2220 http://marketpublishers.com

Table 19. Biosimilar hGH Share of Originator Drug Sales in the EU by Country: 2011 (includes corresponding Graph/Chart) New Indications to Drive Future Growth B. Market Analytics

Table 20. European Recent Past, Current and Future Analysis for Human Growth Hormone Drugs by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 21. European Historic Analysis for Human Growth Hormone Drugs by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) Table 22. European 15-Year Perspective for Human Growth Hormone Drugs by Geographic Region Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2014, and 2020 (includes corresponding Graph/Chart) 4A. FRANCE Market Analysis

Table 23. French Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 24. French Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 4B. GERMANY A. Market Analysis Current & Future Analysis Sandoz International GmbH – A Leading German Player B. Market Analytics

Table 25. German Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 26. German Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 4C. ITALY Market Analysis

Table 27. Italian Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding

Human Growth Hormone Drugs: Market Research Report

7

Phone: +44 20 8123 2220 http://marketpublishers.com

Graph/Chart) Table 28. Italian Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 4D. THE UNITED KINGDOM Market Analysis

Table 29. The UK Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 30. The UK Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 4E. SPAIN Market Analysis

Table 31. Spanish Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 32. Spanish Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 4F. REST OF EUROPE A. Market Analysis Current & Future Analysis Strategic Corporate Developments Select Key Players B. Market Analytics

Table 33. Rest of Europe Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 34. Rest of Europe Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 5. ASIA-PACIFIC A. Market Analysis Current & Future Analysis Biosimilar Regulations in Asian Countries South Korea China India Strategic Corporate Developments Genescience Pharmaceuticals Co. , Ltd. – A Leading Chinese Player

Human Growth Hormone Drugs: Market Research Report

8

Phone: +44 20 8123 2220 http://marketpublishers.com

B. Market Analytics

Table 35. Asia-Pacific Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 36. Asia-Pacific Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) 6. REST OF WORLD A. Market Analysis Current & Future Analysis Strategic Corporate Development Teva Pharmaceutical Industries Limited - A Key Player B. Market Analytics

Table 37. Rest of World Recent Past, Current and Future Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart) Table 38. Rest of World Historic Analysis for Human Growth Hormone Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart) IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 30 (including Divisions/Subsidiaries - 33) The United States (12) Japan (1) Europe (10) Germany (3) The United Kingdom (2) Rest of Europe (5) Asia-Pacific (Excluding Japan) (8) Middle East (2)

Human Growth Hormone Drugs: Market Research Report

9

Powered by TCPDF (www.tcpdf.org)

Phone: +44 20 8123 2220 http://marketpublishers.com

I would like to order: Product name: Product link: Product ID: Price:

Human Growth Hormone Drugs: Market Research Report http://marketpublishers.com/r/HA07779AC1EEN.html HA07779AC1EEN US$ 4,950.00 (Single User License / Electronic Delivery)

If you want to order Corporate License or Hard Copy, please, contact our Customer Service: [email protected]

Payment To pay by Credit Card (Visa, MasterCard, American Express, PayPal), please, click 'BUY NOW' button on product page http://marketpublishers.com/r/HA07779AC1EEN.html

To pay by Wire Transfer, please, fill in your contact details in the form below: First name: Last name: E-mail: Company: Address: City: Zip/Post Code: Country: Tel: Fax: Your message:

* All fields are required

Customer Signature _______________________________________ Please, note that by ordering from MarketPublisher.com you are agreeing to our Terms & Conditions at http://marketpublishers.com/docs/terms_conditions.html

To place an order via fax simply print this form, fill in the information below and fax the completed form to +44 20 7900 3970